About Perspectum
Perspectum is a global medical technology company advancing quantitative imaging for metabolic, liver, and multi-organ health assessment. The company's proprietary technology extracts actionable biomarkers from medical imaging in an intuitive and streamlined way, moving beyond conventional one-dimensional diagnostics to provide comprehensive, multi-dimensional insights. Perspectum's solutions are designed to be safe, fast, and accessible, helping healthcare providers deliver precision medicine tailored to individual patient needs. The company offers solutions across two primary segments: pharma solutions supporting drug development and clinical trials in areas including body composition, cardiometabolic disease, autoimmune disease, MASLD/MASH & cirrhosis, gastrointestinal disease, and oncology; and clinical solutions including LiverMultiScan, CoverScan, MRCP+, Hepatica, and the Perspectum Portal. These technologies enable non-invasive assessment and monitoring of complex conditions. Founded by renowned physicians and scientists including co-founder Sir Michael Brady, Perspectum collaborates with world-leading experts to accelerate research on metabolic diseases, cancer, diabetes, and other chronic conditions. The company operates the Oxford Community Diagnostic Centre and has established partnerships to expand access to advanced MRI diagnostics. Perspectum's patient-first approach emphasizes that every case is unique, with a goal of building a kinder healthcare system through customized solutions and better outcomes.
Mission & Story
Mission
Our goal is to enable healthcare providers to tailor precision medicine to the needs of the individual
Founding Story
The company was co-founded by Sir Michael Brady, a renowned physician and scientist. Sir Mike Brady was elected as an International Member of the National Academy of Engineering in 2025, reflecting the scientific leadership behind the company's founding.
Clinical Focus
Medical conditions and clinical areas addressed by Perspectum.
Who It Serves
Milestones & Awards
Recent Milestones
Partnership with InHealth announced December 2025 to expand Oxford CDC capacity and widen UK MRI access. Strategic partnership with Avant Santé announced December 2025 for Latin America expansion. Published economic analysis on cT1 biomarker for resmetirom treatment September 2025. Executive leadership changes with Dr. Rexford Newbould appointed Interim Chief Executive January 2025.
Awards & Recognition
Co-founder Sir Michael Brady elected as International Member of the National Academy of Engineering (NAE) in February 2025
Key Partnerships
Social & Media
Latest Updates
Perspectum Announces Executive Leadership Changes
Perspectum and InHealth announce national diagnostics partnership to boost Oxford CDC capacity and widen access to advanced MRI across the UK
New analysis shows corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States
Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development
Sir Mike Brady Elected as an International Member of the National Academy of Engineering
Company Details
- Founded
- 2012
- Headquarters
- Oxford, England, United Kingdom
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.